Effect of bemethyl on glycogen metabolism in hepatocytes of diseased human liver
Comparison in people · 2002
- What was studied
- Hepatocyte measurements from patients with chronic hepatitis and cirrhosis
- Main finding
- Reports changes in glycogen content and composition versus basic therapy. Structural liver abnormalities persisted and metabolic indices did not normalize.
Glycogen decrease versus glucose-6-phosphatase activity · r = 0.75 · p<0.05
Reported findings and study design
Hepatocyte glycogen analysis in patients with chronic hepatitis or cirrhosis; Bemitil compared with basic treatment.
Population or model Hepatocyte measurements from patients with chronic hepatitis and cirrhosis
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Glycogen decrease versus glucose-6-phosphatase activity | r = 0.75 | p<0.05 |
| Glycogen decrease versus pretreatment glycogen level | r = 0.87 | p<0.01 |
| Metabolic normalization | Not complete | Structural liver abnormalities also persisted |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Biochemical measures are not survival, fibrosis reversal or confirmed clinical recovery.
- Allocation, sample size and clinical endpoints need the full paper.
Source details
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Sources checked
Citation
M. V. Kudriavtseva, N. N. Bezborodkina, S. V. Okovityi, O. V. Ivanova, B. N. Kudriavtsev. Effect of bemethyl on glycogen metabolism in hepatocytes of diseased human liver Tsitologiia. 44(7):668–675. PMID 12455377